Unfortunately, the lack of species cross-reactivity of A-552 to mouse IL-36α or IL-36γ precluded assessing the effects of this inhibitor in preclinical mouse models of psoriasiform dermatitis induced by injection of IL-23 or the TLR7 agonist IMQ. This evidence concerns the gene TLR7 and Psoriasiform dermatitis.